Tiny implants, big smiles: new study tests slim tooth replacements

NCT ID NCT06528587

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested narrow dental implants in 17 patients who were missing a single tooth in the front of the mouth and had limited bone space. The goal was to see if these smaller implants could work well without needing more complex surgeries. Researchers measured bone loss around the implant and checked for complications and appearance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

17 people

The number who actually took part.

Started

Sep 2024

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged \>18 years, in good general health, who have undergone implant rehabilitation of single edentulism in the anterior region will be selected.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who have undergone implant surgery to perform implant rehabilitation of single edentulism in the anterior region to insert a reduced diameter implant; * ASA I and ASA II patients; * Age \> 18yr; * Non-smokers or smokers ≤ 5 cig/day; * Achievement of FMPS and FMBS ≤ 15%; * Signing of the written informed consent to participate in the study. Exclusion Criteria: * Severe general medical pathologies; * Immunodeficiency states; * Radiotherapy in the head and neck region; * Uncontrolled diabetes or hypertension; * Smokers \>5 cigs/day; * Impossibility to carry out homogeneous and continuous follow-up; * Documented allergy to the biomaterials used; * Pregnancy or breastfeeding; * Inability to provide written informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Implant complication are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione Policlinico Universitario A. Gemelli IRCCS

    Rome, Roma, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.